May 08, 2025

mRNA Combo Vaccine Effective Against Respiratory Viruses

A phase III trial of mRNA-1083 demonstrates immunogenicity and acceptable safety profile in adults 50 years and older.

Conexiant

May 08, 2025

Early Menopause Linked to Long-Term Cognitive Decline, Study

A large UK-based cohort study found that early menopause—before age 40—is associated with both higher depressive symptoms and worse cognitive function over time.

Conexiant

May 08, 2025

Diet Patterns Affect Menarche Timing

New research reveals healthier diets delay menarche while inflammatory diets accelerate it, potentially impacting long-term health outcomes in women regardless of BMI.

Conexiant

May 08, 2025

Doctors Gas Up Vulvovaginal Patients: Study

New research reveals over 50% of patients with vulvovaginal disorders considered abandoning care due to dismissive clinician behaviors, with many reporting their symptoms were disbelieved or trivialized.

Conexiant

May 05, 2025

Links Between HPV and Thyroid Eye Disease

Researchers find “molecular mimicry between HPV capsid protein and key autoimmunity targets in TED,” but further studies are needed to confirm the connection

Conexiant

May 05, 2025

FDA Monthly Round-up: Key April Updates

April’s FDA approvals feature first-in-class therapies, targeted biologics, expanded indications, and innovative delivery systems across allergy, endocrinology, rheumatology, oncology, infectious diseases, and more.

Conexiant

May 02, 2025

Psychotherapy, Family Tied to Better Outcomes

In a large meta-analysis, researchers identified the most effective components of collaborative care for treating depression in primary care.

Conexiant

May 02, 2025

Personalizing Eating Disorder Care Advances, Study

A global research team reviewed current treatments for eating disorders and found that while personalization is seen as essential by patients and clinicians, most approaches still lack strong supporting evidence.

Conexiant

May 02, 2025

Adavosertib in Recurrent or Persistent Uterine Serous Carcinoma

In the phase IIb ADAGIO trial, reported in the Journal of Clinical Oncology, Liu et al found that the Wee1 inhibitor adavosertib showed some activity in patients with recurrent or persistent uterine s...

The ASCO Post